Principal Investigator

Prof. Dr. Angray S. Kang 

Professor of Immunotechnology

analysis-4402809_1920.jpg

Our Researchers & Collaborators

The Scripps Research Institute

Dr. Thomas Stratman

Assistant Professor, University of Barcelona

Dr. Haining Huang

Founder and CSO, Cytimm Therapeutics

Dr. Rener Xu

Associate Professor
Institute of Developmental Biology and Molecular Medicine
Fudan University

Dr. Philip Hoffman

Team Leader at Morphosys (Antibody Phage Display Biotech)

University of Westminster

(PhD student 2007-11)

Currently a lecturer at Institute of Clinical Pharmacology, Central South University, Changsha, China.

PhD student (2006-11)

PhD student (2008-2012)

Dr. Babak Afrough

Senior scientist at PHE Porton Down

PhD student (2006-2010)

Postdoc at the Patterson Institute Manchester, currently Scientific Director Axonova, Mauritius

PhD student (2006-10)

Postdoc at University of Ohio, USA

Queen Mary, University of London

(PhD student 2014-17)

Working in science communications

PhD student (2016-19)

Scientist CRT Protein Core Facility

Dr Nicola Vickaryous

Post-Doctoral Research Scientist 


Dried blood spot sampling for COVID 19  exposure and vaccine response in pwMS

Dr Adrienne Morgan

Honorary Senior Lecturer, Centre for Tumour Biology
 

COVID exposure and vaccine responses in different healthcare settings a longitudinal study

Dr Yassmin Abdelhamid

NIHR Post-Doctoral Research Scientist 2022

Rapid, Sensitive Detection of Resistance to Therapeutic Antibodies

Dr Sanjukta Sarker

NIHR Post-Doctoral Research Scientist 2022

Rapid, Sensitive Detection of Resistance to Therapeutic Antibodies

Student Researchers, PhD

Ghfren Aloraini

Completing

Supervision: Farida Fortune & Angray Kang

Helen Lock

Part-time

Supervision: Farida Fortune & Angray Kang

Dr Arsalan Mirza

January 2017- present
 

Supervision: Angray Kang & Mike Curtis, KCL

Yunying Huang

September 2017-present

Supervision: Hong Wan & Angray Kang

Georgia Leisegang

January 2019-present

Supervision: Farida Fortune & Angray Kang

Grace Megan Howells

January 2019-present

Supervision: Louisa James & Angray Kang

Ellie Sturmey

September 2019-present

Supervision: Andrea Malaspina & Angray Kang

Dr Randy Chance

January 2020-present

Supervision: Angray Kang, Louisa James & Mike Curtis, KCL

Megan Downes

September 2020

Supervision: Angray Kang & Ewan Main

Student Researchers, MSc

Dr Nobel Dias

Experimental Oral Pathology (2013)

Investigating the dimerization of recombinant single chain antibody with KillerRed.

Sayf Aziz

Experimental Oral Pathology (2013)

Investigating functionality of the recombinant fluorescent antibodies 4D5-8mRFP linked to human Fc CH2-CH3

Dr Elham Sahafi

Oral Biology (2015)
 

Novel neovasculature targeting polypeptide

Erin Mari Konicki

Immunology (KCL, 2016)


Human anti-EBOLA antibody library assembly

Lilam Rai

Experimental Oral Pathology (2016)


Generation of recombinant Porphyromonas gingivalis antigens

Tahshin Rahman

Neuroscience and Translational Medicine (2016)


The development of a human anti-alemtuzumab antibody assay

Dr Arsalan Mirza

Oral Biology (2016)


Isolation and characterization of recombinant human monoclonal antibodies against Porphyromonas gingivalis gingipains

Dr Salih Munir

Oral Biology (2016)


Engineering recombinant statherin polypeptide

Dr Sehrish Mubeen

Experimental Oral Pathology (2016)


Recombinant antibodies

Dr Sherif Hatem Abdel Aziz Afify Shabayek

Experimental Oral Pathology (2018)


Development and application of an assay to detect anti-infliximab and anti-Adalimumab antibodies in the sera of Behçet’s syndrome patients

Dr Aseel Atif

Experimental Oral Pathology (2019)


Development of an assay to detect anti-Ustekinumab antibodies

Dr Randy Chance

Experimental Oral Pathology (2019)

Molecular dissection of the human antibody response against OMVs of P. gingivalis

Dr Sihem Houacine

Experimental Oral Pathology (2019)

Induction of p53 by Behçet’s patient sera in keratinocyte cultures

Charles Roberts

Neuroscience and Translational Medicine (2020)

 

COVID-19 impact on MS patients on DMT

Triska Miran

Medical Microbiology (2020)


COVID-19 Seroconversion assays

Dr Vishakha Hiren Thanki

MSc Exp Oral Pathology 2022

Omicron exposure in Dental Hospital workers: a longitudinal study

Dr Rameesha Naeem

MSc Exp Oral Pathology 2022

Omicron exposure in Dental Hospital workers: a longitudinal study

Dr Aliaa Ehab Mohamed Hamdy Elnashar

MSc Exp Oral Pathology 2022

Omicron exposure in Dental Hospital workers: a longitudinal study

Dr Ekinado Mary Ewhrudjakpor

MSc Exp Oral Pathology 2022

Molecular dissection of the human antibody response against OMVs of P. gingivalis

Sukirthan Ramanathan

Medical Microbiology (2022)

Generating a novel anti-Plasmodium falciparum CSP recombinant antibody for preventing malaria

Student Researchers, DClinDent

Dr Abdalrahman M. Ainousa

Paediatric Dentistry (2019)


Preparation and evaluation of recombinant Statherin

Student Researchers, iBSc

Shalini Nadarajan

Experimental Pathology (2016)

Novel assay for detecting the human anti rituximab antibody response using Ritux-GloBody

Ioannis John Theocharopoulos

Neuroscience (2017)

Novel assay for detecting the human anti alemtuzumab antibody response. Alem-GloBody

Gauri Saxena

Neuroscience (2018)

Detecting Anti-Alemtuzumab Antibodies

Tanya Fahmy

Experimental Pathology (2019)

Developing an assay for anti-emicizumab antibodies in patients with Haemophilia A

George Rose

Experimental Pathology (2020)

Anti-drug antibodies, their impact on monoclonal antibody therapies

Aliye Nazli Asardag

Neuroscience and Trauma (2021)

Monitoring the response to COVID-19 vaccination in people with MS undergoing treatment with DMT’s

Olivia Rebecca McIver

Experimental Pathology (2021)

Monitoring COVID-19 antibody level in Dental Hospital workers

Olivia Amy Quinn

Neuroscience and Trauma (2021)

Developing an assay for anti-ocrelizumab antibodies in people with multiple sclerosis treated with ocrelizumab

Carrie H. Y. Chew

Rod Flowers Summer Student (2021)

Bispecific Antibody targeting B-cell subsets

Madeleine Rhiannon Jones

Rod Flowers Summer Student (2021)

SARS-COV2 RBD GloBody assay in dried blood spots from pwMS

Radhika Patel

Experimental Pathology (2021)

Generating a novel anti-Plasmodium falciparum CSP recombinant antibody for preventing malaria

Muhammad Anjum

Experimental Pathology (2021)

Determining anti-Rituximab anti-drug antibodies in pwMS, a study with Karolinska

Sander Valente Ianniello

Neuroscience and Trauma (2022)

Determining anti-Rituximab anti-drug antibodies in pwMS, a study with Karolinska

Student Researchers, BSc

Sarah Naomi Oommen

Biomedicine (2016)

Constructing a vector for the rapid screening of recombinant human monoclonal antibodies with a disease focus in P. gingivalis

Nisha Thaslima Aziz

Biomedicine (2017)

Development of an assay to detect Anti-Alemtuzumab-Antibodies in Multiple Sclerosis patients treated with Alemtuzumab

Salwa Elomky

Biomedicine (2017)

The Detection of Anti-Drug Antibodies in Multiple Sclerosis Patients Treated with Alemtuzumab

Saatvik Potluri

Biomedicine (2018)

Evaluation of Vibrio natriegens (Vmax) for recombinant antibody expression and secretion

Dizem Tekin

Biomedicine (2019)

A test for detecting anti-drug antibodies in patients treated with Humira®, a monoclonal antibody against TNFα

Roda Mohammed

Biomedicine (2019)

Detecting anti-drug antibodies in patients treated with Remicade® a monoclonal antibody against TNFα

Collaborators

Prof David Baker

Prof Klaus Schmierer

Prof Farida Fortune CBE

Dr Ruth Dobson

Prof Gavin Giovannoni

Dr Sharmilee Gnanapavan

Prof Mike Makris

Prof Richard Pickersgill

Point of Care Diagnostics

Prof Mike Curtis

Dr Pradeep Kumar Sacitharan

Dr James Garnett

Dr Liaqat Ali